✦ LIBER ✦

Phase II study results on safety and efficacy of CAELYX® (DOXIL®) in combination with paclitaxel in the treatment of metastatic breast cancer

✍ Scribed by Woll, P.J.; Carmichael, J.; Chan, S.; Howell, A.; Ranson, M.; Miles, D.; Calvert, H.; Welbank, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5003 Phase II study of sunitinib in comb

✍ J.Y. Blay; A. Lluch; M. Gutierrez; M. Martin; M.F. Kozloff; C. Prady; V. Tassell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Efficacy and safety of three-weekly herc

✍ S. Verma; B. Leyland-Jones; J.-P. Ayoub; K. Gelmon; A. Arnold; C. Szakacs; J. Ho 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A phase II study of gemcitabine plus pac

✍ Binghe XU; Zhenzhou SHEN; Zefei JIANG; Zhongzhen GUAN; Xiaoqing ZHANG 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Phase II study of gemcitabine and doceta

✍ Shom GOEL; Ehtesham ABDI; Craig R LEWIS; Matthew LINKS; Steven BEGBIE; Philip CL 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Capecitabine plus paclitaxel versus epir

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

360 Phase I/II study with paclitaxel in

✍ U. Klaassen; H. Wilke; D. Strumberg; C. Philippou Pari; A. Harstrick; W. Eberhar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB